NIH, Merck and Gates MRI completes phase I trial of TBD09/MK-7762 TB drug candidate: Our Bureau, Bengaluru Wednesday, January 14, 2026, 14:45 Hrs [IST] Merck, known as MSD outside ...
The New Times on MSNOpinion
The future can be bright in the fight against TB
As we start the new year, contrary to what you may have heard, Africa can build off of significant progress against a disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback